首页> 外文期刊>Sensors >Fluorescent Imaging for Assessment of the Effect of Combined Application of Electroporation and Rifampicin on HaCaT Cells as a New Therapeutic Approach for Psoriasis
【24h】

Fluorescent Imaging for Assessment of the Effect of Combined Application of Electroporation and Rifampicin on HaCaT Cells as a New Therapeutic Approach for Psoriasis

机译:荧光成像评估电穿孔和利福平联用对HaCaT细胞的作用,作为治疗牛皮癣的新方法

获取原文
           

摘要

The study aimed to clarify the role of electric pulses in combination with chemotherapy on the viability of keratinocyte cell line HaCaT, in the context of its application as a new therapeutic approach for psoriasis. The data show that electroporation of HaCaT cells in combination with rifampicin induces cytoskeleton disruption and increases permeability of cell monolayer due to cell-cell junctions' interruption, visualized by fluorescent imaging of E-cadherin and actin integrity. This was accompanied with synergistic reduction of cell viability. The study proposes a new opportunity for more effective skin treatment than chemotherapy. The future application of this electrochemotherapeutic approach for combined local treatment of psoriasis may have serous benefits because of a high possibility to avoid side-effects of conventional chemotherapy.
机译:该研究旨在阐明电脉冲联合化学疗法在角质形成细胞系HaCaT的生存能力中的作用,并将其作为银屑病的新治疗方法。数据显示,HaCaT细胞与利福平联合电穿孔可诱导细胞骨架破坏,并由于细胞间连接的中断而增加细胞单层的通透性,可通过E-钙粘蛋白的荧光成像和肌动蛋白完整性来观察。这伴随着细胞活力的协同降低。该研究提出了比化学疗法更有效的皮肤治疗的新机会。这种电化学治疗方法在银屑病联合局部治疗中的未来应用可能会带来很多好处,因为它可以避免常规化学疗法的副作用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号